The revised estimates, based on software modeling, also show that only 1,300 Fijians are receiving antiretroviral therapy for ...

EQS-News: Benzinga / Key word (s): Science Soligenix's Leadership Aims To Drive Growth In Rare Disease Markets In 2025 And ...

Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity ...

Tremfya could become the first IL-23 inhibitor with fully subcutaneous induction and maintenance options in the treatment of ...

Bruins coach Joe Sacco said he "wouldn’t expect (McAvoy) in the short-term" as the franchise defenseman remains hospitalized.

Fact checked by Nick Blackmer The U.S. is seeing a severe flu season this year, with the CDC estimating at least 24 million ...

Yeast infection” is the term used to describe chronic and persistent fungal infections of the skin, mouth, digestive system ...

Combining an existing small-molecule protein therapy called tumor necrosis factor related apoptosis-inducing ligand (TRAIL) ...

Intra-Cellular Therapies’ CAPLYTA is making waves in the antipsychotic market, gaining traction as a novel treatment for schizophrenia and bipolar depression. With its differentiated safety profile ...

In August 2024, the FDA approved LYMPHIR, a targeted immunotherapy for an initial indication in the treatment of cutaneous T-cell ... drugs that can be administered with a simple intravenous infusion.

In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™ for all indications matching the reference ...

Takeaways Bioidentical hormone therapy (BHT) offers a natural approach to hormone balance, but compounded versions lack FDA regulation, raising safety concerns. Professional organizations recommend ...